s6y
Company name or ticker
Search
Oncotelic Therapeutics, Inc.
POS AM
Post-effective amendment to a registration statement that is not immediately effective upon filing
Filed
Friday, August 14, 2009
Accession number
0000950123-09-035562
Documents
Oxigene, Inc.
POS AM
Certifications, consents and other formalities
1
Ex-23.1 Consent of Ernst & Young LLP
23.1
Ex-23.1 Consent of Ernst & Young LLP
EX-23.1
On sec.gov
Filing index
All files
Complete submission text
SGML header